EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PTPRE promotes gastric cancer cell resistance to 5-fluorouracil by inhibiting ferroptosis via the Src/FAK/TRIB3 axis

Ming Liu, Xiaomei Liao, Fangchao Wang, Pengqing Jiao, Zhongkai Wang iD

PLOS One · 18.06.2026 · 21 (6) · e0351846

DOI: 10.1371/journal.pone.0351846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 18.06.2026. Verfasst von Ming Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Fluorouracil, Drug Resistance, Neoplasm, Ferroptosis. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science Research Project of Hebei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acquired drug resistance is a major cause of failure in gastric cancer treatment. The protein tyrosine phosphatase receptor type E (PTPRE) plays an oncogenic role in certain tumours; however, its function in chemotherapy-resistant gastric cancer remains unclear. Therefore, we analysed PTPRE expression in gastric cancer using The Cancer Genome Atlas. In vitro experiments were then conducted to investigate the effects of PTPRE on the resistance of cancer cells to 5-fluorouracil (5-FU) and its potential mechanisms. The results were further validated in vitro using xenograft studies. We found that PTPRE is upregulated in gastric cancer tissues and participates in the induction of 5-FU resistance. Mechanistic studies revealed that PTPRE suppressed ferroptosis in gastric cancer cells and promoted 5-FU resistance by activating the Src/FAK pathway to upregulate TRIB3 expression. In summary, PTPRE suppresses ferroptosis in gastric cancer cells via the Src/FAK/TRIB3 signalling pathway, thereby inducing 5-FU resistance. Intervention with PTPRE and its downstream targets may represent a potential approach for the clinical treatment of 5-FU-resistant gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsFluorouracilDrug Resistance, NeoplasmFerroptosisProtein Serine-Threonine KinasesCell Cycle ProteinsRepressor ProteinsReceptor-Like Protein Tyrosine Phosphatases, Class 3HumansAnimalsCell Line, TumorSignal TransductionMicesrc-Family KinasesFocal Adhesion Kinase 1Gene Expression Regulation, NeoplasticMice, NudeXenograft Model Antitumor AssaysAntimetabolites, Antineoplastic

Substanzen

FluorouracilPTK2 protein, humansrc-Family KinasesFocal Adhesion Kinase 1Protein Serine-Threonine KinasesCell Cycle ProteinsRepressor ProteinsReceptor-Like Protein Tyrosine Phosphatases, Class 3Antimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Pain and Rehabilitation, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Rheumatology and Immunology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

ORCID-Profile: Zhongkai Wang

Förderung

  • Medical Science Research Project of Hebei

Zitieren

APA

Liu, M., Liao, X., Wang, F., Jiao, P., & Wang, Z. (2026). PTPRE promotes gastric cancer cell resistance to 5-fluorouracil by inhibiting ferroptosis via the Src/FAK/TRIB3 axis. PLOS One, 21(6), e0351846. https://doi.org/10.1371/journal.pone.0351846

Vancouver

Liu M, Liao X, Wang F, Jiao P, Wang Z. PTPRE promotes gastric cancer cell resistance to 5-fluorouracil by inhibiting ferroptosis via the Src/FAK/TRIB3 axis. PLOS One. 2026;21(6):e0351846. doi:10.1371/journal.pone.0351846

BibTeX
@article{Liu2026,
  author = {Liu, Ming and Liao, Xiaomei and Wang, Fangchao and Jiao, Pengqing and Wang, Zhongkai},
  title = {PTPRE promotes gastric cancer cell resistance to 5-fluorouracil by inhibiting ferroptosis via the Src/FAK/TRIB3 axis},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0351846},
  doi = {10.1371/journal.pone.0351846}
}
Kostenlos starten →